US FDA Extends Safety-Reporting Deadline For Certain Combination Products, Issues Guidance
Executive Summary
After issuing a major combination product post-market safety reporting rule at the end of 2016, US FDA released guidance to add context for companies developing the products. The agency has also extended compliance deadlines in many cases until 2019.
You may also be interested in...
Combination Product Reporting Rule Set For 2020 Enforcement
US FDA's long-delayed final rule on postmarketing safety reporting will mostly go into effect next July, though manufacturers who file reports via the Vaccine Adverse Event Reporting System have a little extra time, with their compliance date set for 31 January 2021.
Combination Product Reporting Rule Set For 2020 Enforcement
Most combination product applicants will need to comply with an FDA final rule on postmarketing safety reporting as of 31 July 2020.
US FDA Delays Combo Safety Guidance Deadlines Again After Industry Feedback
Industry concerns they won’t meet a deadline from the FDA to comply with a combination products safety reporting requirement has led the agency to again push back a couple of implementation deadlines by a year.